1540 ET - Truist analysts aren't big fans of Church & Dwight's $880 million acquisition of the Touchland hand-sanitizer business. "While it brings accretive growth and margins and checks the company's stated criteria for M&A, we are skeptical about the long term opportunity," the analysts said in a research note. For one, Truist doesn't believe that Church & Dwight has ample experience in the beauty channel and competing against bigger players, who may eye expanding into the scented hand sanitizer if the category continues to do well. The analysts also don't think that Touchland quite has the brand equity as other recent Church & Dwight acquisitions such as Therabreath or differentiated innovation like Hero, which makes the acne-fighting Mighty Patch. Church & Dwight up 3.8% at $95.01. (paul.ziobro@wsj.com)
(END) Dow Jones Newswires
May 12, 2025 15:40 ET (19:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.